Arca Biopharma Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Arca Biopharma Inc..The latest application filed is for "methods and compositions involving bucindolol for the treatment of atrial fibrillation".
- Arca Biopharma Inc. - Broomfield CO
- ARCA Biopharma, Inc. - Westminster CO
- ARCA BIOPHARMA, INC - Westminster CO US
- Arca Biopharma Inc. - Bloomfield CO
- ARCA BIOPHARMA INC. -
Trademarks
| Patent | Date |
|---|---|
| Methods and compositions involving (S)-bucindolol Grant 11,452,712 - Bristow , et al. September 27, 2 | 2022-09-27 |
| Methods And Compositions Involving Bucindolol For The Treatment Of Atrial Fibrillation App 20210251962 - Bristow; Michael ; et al. | 2021-08-19 |
| Methods and compositions involving bucindolol for the treatment of atrial fibrillation Grant 10,925,856 - Bristow , et al. February 23, 2 | 2021-02-23 |
| Methods And Compositions Involving Bucindolol For The Treatment Of Atrial Fibrillation App 20200268710 - Bristow; Micheal ; et al. | 2020-08-27 |
| Methods And Compositions Involving (s)-bucindolol App 20190358204 - Bristow; Michael R. ; et al. | 2019-11-28 |
| Methods And Compositions Involving (s)-bucindolol App 20180161309 - Bristow; Michael R. ; et al. | 2018-06-14 |
| Antibodies To Ntb-a App 20170334989 - Abo; Arie ; et al. | 2017-11-23 |
| Methods and compositions involving (S)-bucindolol Grant 9,763,916 - Bristow , et al. September 19, 2 | 2017-09-19 |
| Methods and Compositions Involving (S)-Bucindolol App 20170000766 - Bristow; Michael R. ; et al. | 2017-01-05 |
| Methods and compositions involving (S)-bucindolol Grant 9,446,023 - Bristow , et al. September 20, 2 | 2016-09-20 |
| Antibodies To Ntb-a App 20150376273 - Abo; Arie ; et al. | 2015-12-31 |
| Methods And Compositions Involving (s)-bucindolol App 20150190375 - Bristow; Michael R. ; et al. | 2015-07-09 |
| Antibodies to NTB-A Grant 8,993,726 - Abo , et al. March 31, 2 | 2015-03-31 |
| Methods and compositions involving (S)-bucindolol Grant 8,946,284 - Bristow , et al. February 3, 2 | 2015-02-03 |
| Antibodies To Lrp6 App 20140220040 - Abo; Arie ; et al. | 2014-08-07 |
| Antibodies to LRP6 Grant 8,715,941 - Abo , et al. May 6, 2 | 2014-05-06 |
| Antibodies to CLL-1 Grant 8,536,310 - Abo , et al. September 17, 2 | 2013-09-17 |
| Antibodies to NTB-A Grant 8,193,320 - Abo , et al. June 5, 2 | 2012-06-05 |
| Methods And Compositions Involving (s)-bucindolol App 20120108617 - Bristow; Michael R. ; et al. | 2012-05-03 |
| Methods and compositions concerning antibodies that bind CD84-like polypeptides Grant 7,981,413 - Kuo , et al. July 19, 2 | 2011-07-19 |
| Antibodies To Ntb-a App 20110171204 - Abo; Arie ; et al. | 2011-07-14 |
| Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor Grant 7,951,381 - Funk , et al. May 31, 2 | 2011-05-31 |
| Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides App 20100305003 - Tang; Y. Tom | 2010-12-02 |
| Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides App 20100292155 - Tang; Y. Tom | 2010-11-18 |
| Stem cell factor-like proteins and uses thereof Grant 7,674,890 - Boyle , et al. March 9, 2 | 2010-03-09 |
| NCAGE Code | 5UH68 | ARCA BIOPHARMA INC. |
| CAGE Code | 5UH68 | ARCA BIOPHARMA, INC. |
| DUNS | 849317615 | ARCA BIOPHARMA, INC. |
| SEC | 0000907654 | ARCA biopharma, Inc. of DELAWARE |
| SEC | 907654 | ARCA biopharma, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 